Anaptysbio (ANAB) Total Debt (2016 - 2019)

Anaptysbio's Total Debt history runs 4 years deep, the most recent figure standing at $3.1 million for Q3 2019.

• Quarterly Total Debt rose 28.68% year-over-year to $3.1 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.1 million (up 28.68% YoY) and the FY2018 annual result came in at $625000.0, down 91.73% from the prior year.
• Total Debt was $3.1 million for Q3 2019 at Anaptysbio, down from $4.8 million in the prior quarter.
• Across five years, Total Debt topped out at $13.8 million in Q4 2016 and bottomed at $625000.0 in Q4 2018.
• A 4-year average of $6.8 million and a median of $6.2 million in 2018 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2018 — Total Debt slumped 91.73% — and 2019, when it climbed 28.68%.
• Anaptysbio's Total Debt stood at $13.8 million in 2016, then slumped by 45.3% to $7.6 million in 2017, then slumped by 91.73% to $625000.0 in 2018, then soared by 396.0% to $3.1 million in 2019.
• Business Quant data shows ANAB's Total Debt at $3.1 million in Q3 2019, $4.8 million in Q2 2019, and $6.5 million in Q1 2019.